Biotech Life Sciences Trade Mission to Australia, 35353-35355 [2012-14452]

Download as PDF erowe on DSK2VPTVN1PROD with NOTICES Federal Register / Vol. 77, No. 114 / Wednesday, June 13, 2012 / Notices A. Export or reexport to or on behalf of the Persons Subject to this Order any item subject to the Regulations; B. Take any action that facilitates the acquisition or attempted acquisition by the Persons Subject to this Order of the ownership, possession, or control of any item subject to the Regulations that has been or will be exported from the United States, including financing or other support activities related to a transaction whereby the Persons Subject to this Order acquire or attempt to acquire such ownership, possession or control; C. Take any action to acquire from or to facilitate the acquisition or attempted acquisition from the Persons Subject to this Order of any item subject to the Regulations that has been exported from the United States; D. Obtain from the Persons Subject to this Order in the United States any item subject to the Regulations with knowledge or reason to know that the item will be, or is intended to be, exported from the United States; or E. Engage in any transaction to service any item subject to the Regulations that has been or will be exported from the United States and which is owned, possessed or controlled by the Persons Subject to this Order, or service any item, of whatever origin, that is owned, possessed or controlled by the Persons Subject to this Order if such service involves the use of any item subject to the Regulations that has been or will be exported from the United States. For purposes of this paragraph, servicing means installation, maintenance, repair, modification or testing. III. In addition to the Related Person named above, after notice and opportunity for comment as provided in section 766.23 of the Regulations, any other person, firm, corporation, or business organization related to the Denied Person by affiliation, ownership, control, or position of responsibility in the conduct of trade or related services may also be made subject to the provisions of this Order if necessary to prevent evasion of the Order. IV. This Order does not prohibit any export, reexport, or other transaction subject to the Regulations where the only items involved that are subject to the Regulations are the foreignproduced direct product of U.S.-origin technology. V. This Order is effective immediately and shall remain in effect until June 3, 2021. VI. In accordance with Part 756 of the Regulations, Vaghari may file an appeal of this Order with the Under Secretary of Commerce for Industry and Security. The appeal must be filed within 45 days VerDate Mar<15>2010 14:45 Jun 12, 2012 Jkt 226001 from the date of this Order and must comply with the provisions of Part 756 of the Regulations. VII. In accordance with Part 756 of the Regulations, the Related Person may also file an appeal of this Order with the Under Secretary of Commerce for Industry and Security. The appeal must be filed within 45 days from the date of this Order and must comply with the provisions of Part 756 of the Regulations. VIII. A copy of this Order shall be delivered to the Denied Person and the Related Person. This Order shall be published in the Federal Register. Issued this 6th day of June, 2012. Bernard Kritzer, Director, Office of Exporter Services. [FR Doc. 2012–14424 Filed 6–12–12; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE International Trade Administration Biotech Life Sciences Trade Mission to Australia International Trade Administration, Department of Commerce. ACTION: Notice. AGENCY: Mission Description The United States Department of Commerce, International Trade Administration, U.S. and Foreign Commercial Service (CS) is organizing a Biotech Life Sciences trade mission to Australia, October 29–November 2, 2012. The mission to Australia is intended to include representatives from a variety of U.S. biotechnology and life science firms. The goals of the trade mission to Australia are to (1) increase U.S. exports to Australia, (2) introduce U.S. participants to potential strategic partners, (3) introduce U.S. participants to industry and government officials in Australia to learn about various opportunities, and (4) to educate the participants about trade policy and regulatory matters involved in doing business in Australia. Participating in an official U.S. industry delegation, rather than traveling to Australia independently, will increase the participants’ profile and enhance the ability to secure meetings in Australia. The mission will include site visit(s) to prominent biotech organizations, government meetings, and briefings and receptions during the AusBiotech National Conference in Melbourne, Australia. Trade mission participants will have the opportunity to interact PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 35353 with CS staff to discuss industry developments, opportunities, and sales strategies. Commercial Setting U.S. biotech and life science firms consider Australia a harbor, with strong intellectual property rights protection and enforcement, and a transitional market that is strategically positioned to serve as a gateway to Asian markets. Australia is the leading biotechnology hub of the Asia-Pacific, with over 1,000 biotechnology companies, and clinical trials that meet the requirements under EU and FDA regulations. The Australian biotechnology sector covers human therapeutics, industrial applications, the agriculture sector, food technology, medical devices and diagnostics, and clean tech. Australia’s consumer base and impressive economic strength further reinforce the importance of the market for U.S. firms. Australia’s US$11.39 billion pharmaceutical market is among the five largest in the Asia-Pacific region. Australia also has the region’s second highest annual spending on medicine, after Japan. Much of this spending is on patented drugs, which account for 67% of the total pharmaceutical expenditure. Australia remains attractive to pharmaceutical firms—per-capita healthcare spending is high (US$5,077) and the regulatory regime is comparable to those in other developed countries. According to UN Comtrade, Australia imported finished medicine worth US$7.1 billion in 2010. Additionally, the current U.S. dollar-Australian dollar exchange rate is advantageous for U.S. product and services exports to Australia. The AusBiotech National Conference is a venue that attracts not only biotech companies in the medical sector, but also in the diagnostics, agriculture, industrial and environmental biotech segments. The annual event has earned a reputation as the industry’s premier biotechnology conference for the Asia Pacific region and has proved its relevance to the Australian and international biotechnology industries, attracting more than 1,100 participants including 233 international participants from 20 countries. This program presents an opportunity for the entire gamut of U.S. biotech companies looking to sell into Australia and spring board into Asia. A U.S. Department of Commerce-led ´ trade mission offers an attractive entree for U.S. firms in the Australian market. Mission Goals The goals of the trade mission to Australia are to (1) increase U.S. exports E:\FR\FM\13JNN1.SGM 13JNN1 35354 Federal Register / Vol. 77, No. 114 / Wednesday, June 13, 2012 / Notices to Australia, (2) introduce U.S. participants to potential strategic partners, (3) introduce U.S. participants to industry and government officials in Australia to learn about various opportunities, and (4) to educate the participants about trade policy and regulatory matters involved in doing business in Australia. Mission Scenario In Melbourne, the U.S. mission members will be briefed by International Trade Administration CS staff, and other key U.S. government officials. Senior American Consulate officials will host a networking event for the group with Australian biotech and life science industry organizations and multipliers. During the mission, U.S. participants will benefit from attending the AusBiotech National Conference, customized one-on-one matchmaking October 29 ................................................. October 31 ................................................. November 1 ............................................... November 2 ............................................... erowe on DSK2VPTVN1PROD with NOTICES Proposed Timetable Mission participants will be encouraged to arrive October 28 or 29, 2012 and the mission program will proceed from October 29 through November 2, 2012. National Conference fee and conference evening dinner on November 1 are included in the mission participation fee. Participation Requirements All parties interested in participating in the Biotech Life Sciences Trade Mission to Australia must complete and submit an application for consideration by the Department of Commerce. All applicants will be evaluated on their ability to meet certain conditions and best satisfy the selection criteria as outlined below. A minimum of 10 and a maximum of 12 participants will be selected for the mission from the applicant pool. U.S. companies already involved with and/or doing business in Australia as well as U.S. companies seeking exposure to the market for the first time are encouraged to apply. Fees and Expenses After a company or trade association has been selected to participate in the mission, a participation fee paid to the U.S. Department of Commerce is VerDate Mar<15>2010 • Transportation to a site visit to Australia’s top biotech company and/or leading research institution; • Meetings with Australian government officials; • Participation in AusBiotech National Conference; • Participation in the U.S. Pavilion at the BioIndustry Exhibition at AusBiotech; • Participation in industry networking events in Melbourne; • Meetings with International Trade Administration CS Australia’s life science industry specialist. Melbourne Arrive Melbourne. Day at leisure. Early evening no-host group dinner Melbourne. Australia market breakfast briefing. Site visit. Networking luncheon and Australian biotechnology briefing. Evening reception. Melbourne AusBiotech National Conference 2012.1 BioPartnering business matchmaking appointments. Conference evening welcome reception. Melbourne AusBiotech National Conference 2012 BioPartnering business matchmaking appointments. Conference evening dinner. Melbourne AusBiotech National Conference 2012. BioPartnering business matchmaking appointments. Conference Closing Reception. October 30 ................................................. 1 AusBiotech with potential partners using the biopartnering.com platform, an efficient and easy to use personalized intelligent scheduling internet platform that facilitates scheduling appointments to connect with key people. And, receive a market briefing by the International Trade Administration Commercial Specialist for the biotech life science sector at the American Consulate, and networking activities. A site visit to Australia’s top biotech company and/or leading research institution will be offered. Participation in the mission will include the following: • Pre-travel briefings/webinar on the Australian market and doing business in Australia; • Pre-scheduled meetings with potential partners in Australia via the biopartnering.com platform; 14:45 Jun 12, 2012 Jkt 226001 required. The participation fee for one company representative will be $4,504 for small or medium-sized enterprises (SME) 2 and $5,321 for large companies, which will cover one representative. The fee for each additional firm representative (large firm or SME/trade association) is $1,370.3 The Commercial Service will assist in booking hotels at favorable rates, but lodging costs, meals and incidental expenses will be the responsibility of each mission participant. 2 An SME is defined as a firm with 500 or fewer employees or that otherwise qualifies as a small business under SBA regulations. Parent companies, affiliates, and subsidiaries will be considered when determining business size. The dual pricing reflects the Commercial Service’s user fee schedule that became effective May 1, 2008. 3 The mission participation fee includes the AusBiotech National Conference registration fee and conference evening dinner on November 1. PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 Conditions for Participation • An applicant must submit a completed and signed mission application and supplemental application materials, including adequate information on the company’s products and/or services, primary market objectives, and goals for participation. If the U.S. Department of Commerce receives an incomplete application, the Department may reject the application, request additional information, or take the lack of information into account when evaluating the applications. • Each applicant must also certify that the products and services it seeks to export through the mission are either produced in the United States, or, if not, marketed under the name of a U.S. firm and have at least fifty-one percent U.S. content. E:\FR\FM\13JNN1.SGM 13JNN1 Federal Register / Vol. 77, No. 114 / Wednesday, June 13, 2012 / Notices • In the case of a trade association or trade organization, the applicant must certify that for each company to be represented by the association or trade organizations, the products and/or services the represented company seeks to export are either produced in the United States or, if not, marketed under the name of a U.S. firm and have at least fifty-one percent U.S. content. Selection Criteria for Participation Contacts U.S. Commercial Service Domestic Contact Aileen Nandi, Senior Commercial Officer, San Jose U.S. Export Assistance Center, 408–535–2757, ext. 102, Aileen.Nandi@trade.gov. Gabriela Zelaya, International Trade Specialist, San Jose U.S. Export Assistance Center, 408–535–2757, ext. 107, Gabriela.Zelaya@trade.gov. Elnora Moye, Trade Program Assistant. Timeframe for Recruitment and Applications erowe on DSK2VPTVN1PROD with NOTICES Selection will be based on the following criteria: • Suitability of a company’s (or in the case of a trade association or trade organization, represented companies’) products or services to the mission’s goals • Company’s (or in the case of a trade association or trade organization, represented companies’) potential for business in Australia, including likelihood of exports resulting from the trade mission • Consistency of the applicant’s (or in the case of a trade association or trade organization, represented companies’) goals and objectives with the stated scope of the trade mission Referrals from political organizations and any documents containing references to partisan political activities (including political contributions) will be removed from an applicant’s submission and not considered during the selection process. AGENCY: Mission recruitment will be conducted in an open and public manner, including publication in the Federal Register, posting on the Commerce Department trade mission calendar (http://export.gov/ trademissions/) and other Internet web sites, press releases to general and trade media, direct mail, notices by industry trade associations and other multiplier groups, and publicity at industry meetings, symposia, conferences, and trade shows. Recruitment for the mission will begin immediately and close on July 15, 2012. Selection decisions will be made on a rolling basis until 10–12 participants are selected. Although applications will be accepted through July 15, 2012, interested U.S. firms and trade associations are encouraged to submit their applications as soon as possible. We will inform applicants of selection decisions as the decisions are made. Applications received after July 15, 2012 will be considered only if space and scheduling constraints permit. VerDate Mar<15>2010 14:45 Jun 12, 2012 Jkt 226001 U.S. Commercial Service Australia Contacts Joe Kaesshaefer, Senior Commercial Officer, American Consulate General—Sydney, Tel: +61–2–9373– 9201, Joe.Kaesshaefer@trade.gov. Monique Roos, Commercial Specialist, American Consulate General— Sydney, Tel: +61–2–9373–9210, Monique.Roos@trade.gov. [FR Doc. 2012–14452 Filed 6–12–12; 8:45 am] BILLING CODE 3510–FP–P DEPARTMENT OF COMMERCE International Trade Administration [Docket No. 120216141–2141–01] RIN 0625–XA17 User Fee Schedule for Trade Promotion Services U.S. & Foreign Commercial Service, International Trade Administration, Department of Commerce. ACTION: Notice and request for comment. The U.S. & Foreign Commercial Service (US&FCS) within the International Trade Administration (ITA) publishes this notice to announce its intent to adjust user fees in light of an independent cost of service study finding, which concluded that the US&FCS is not fully covering its costs for providing trade promotion services under the current fee structure. ITA provides a wide range of trade promotion information and services to U.S. businesses that are exporting or seeking to export. The services considered here are a subset of ITA activities that involve relatively more intensive time engagements with particular client firms; ITA will continue to provide its core information and services without charge. The primary objective of the adjustment to the User Fee Schedule is to ensure that the fees for the more intensive services reflect, to the extent possible, the actual SUMMARY: PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 35355 costs incurred by the United States for providing these more intensive trade promotion services. The fee revenue is expected to continue to contribute to ITA’s capabilities for assisting U.S. businesses in accessing export markets. In addition, in revising the user fees, the US&FCS proposes to revise the small & medium-sized enterprises (SME) hourly rate discount as well as the SME incentive program piloted in 2008. The US&FCS has historically offered a discount to SME’s, defined as those which employ 500 or less persons. Under the User Fee Schedule proposed in this notice, US&FCS will offer a discount of 50 percent per hour to SMEs. The purpose of this notice is to align user fees and authorized activities with actual program costs; and improve our ability to properly recover direct and indirect costs associated with service delivery. DATES: We will consider all comments that we receive on or before 60 days after publication in the Federal Register. ADDRESSES: You may submit comments by either of the following methods: Federal eRulemaking Portal: www.Regulations.gov. Postal Mail/Commercial Delivery: Docket No. ITA–2012–0001 U.S. & Foreign Commercial Service, Office of Strategic Planning & Resource Management, 1400 Constitution Avenue NW., Rm. C125, Washington, DC 20235. Supporting documents and any comments we receive on this docket may be viewed at http:// www.regulations.gov/#!docketDetail; D ITA–2012–0001. SUPPLEMENTARY INFORMATION: Background The statutory mission of US&FCS is to ‘‘place primary emphasis on the promotion of exports of goods and services from the United States, particularly by small businesses and medium-sized businesses, and on the protection of United States business interests abroad * * * through activities that include assisting United States exporters.’’ 15 U.S.C. 4721(b). The statute further defines the term ‘‘United States exporter’’ at 15 U.S.C. 4721(j) as a U.S. citizen, U.S. corporation, or foreign corporation that is more than 95% U.S.-owned that ‘‘exports or seeks to export, goods or services produced in the United States.’’ User fees may be collected from U.S. exporters that meet the Service Eligibility Policy issued in FY 2011. The Office of Management and Budget (OMB) Circular A–25 encourages the E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 77, Number 114 (Wednesday, June 13, 2012)]
[Notices]
[Pages 35353-35355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14452]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


Biotech Life Sciences Trade Mission to Australia

AGENCY: International Trade Administration, Department of Commerce.

ACTION: Notice.

-----------------------------------------------------------------------

Mission Description

    The United States Department of Commerce, International Trade 
Administration, U.S. and Foreign Commercial Service (CS) is organizing 
a Biotech Life Sciences trade mission to Australia, October 29-November 
2, 2012. The mission to Australia is intended to include 
representatives from a variety of U.S. biotechnology and life science 
firms. The goals of the trade mission to Australia are to (1) increase 
U.S. exports to Australia, (2) introduce U.S. participants to potential 
strategic partners, (3) introduce U.S. participants to industry and 
government officials in Australia to learn about various opportunities, 
and (4) to educate the participants about trade policy and regulatory 
matters involved in doing business in Australia. Participating in an 
official U.S. industry delegation, rather than traveling to Australia 
independently, will increase the participants' profile and enhance the 
ability to secure meetings in Australia. The mission will include site 
visit(s) to prominent biotech organizations, government meetings, and 
briefings and receptions during the AusBiotech National Conference in 
Melbourne, Australia. Trade mission participants will have the 
opportunity to interact with CS staff to discuss industry developments, 
opportunities, and sales strategies.

Commercial Setting

    U.S. biotech and life science firms consider Australia a harbor, 
with strong intellectual property rights protection and enforcement, 
and a transitional market that is strategically positioned to serve as 
a gateway to Asian markets. Australia is the leading biotechnology hub 
of the Asia-Pacific, with over 1,000 biotechnology companies, and 
clinical trials that meet the requirements under EU and FDA 
regulations. The Australian biotechnology sector covers human 
therapeutics, industrial applications, the agriculture sector, food 
technology, medical devices and diagnostics, and clean tech. 
Australia's consumer base and impressive economic strength further 
reinforce the importance of the market for U.S. firms.
    Australia's US$11.39 billion pharmaceutical market is among the 
five largest in the Asia-Pacific region. Australia also has the 
region's second highest annual spending on medicine, after Japan. Much 
of this spending is on patented drugs, which account for 67% of the 
total pharmaceutical expenditure. Australia remains attractive to 
pharmaceutical firms--per-capita healthcare spending is high (US$5,077) 
and the regulatory regime is comparable to those in other developed 
countries. According to UN Comtrade, Australia imported finished 
medicine worth US$7.1 billion in 2010. Additionally, the current U.S. 
dollar-Australian dollar exchange rate is advantageous for U.S. product 
and services exports to Australia.
    The AusBiotech National Conference is a venue that attracts not 
only biotech companies in the medical sector, but also in the 
diagnostics, agriculture, industrial and environmental biotech 
segments. The annual event has earned a reputation as the industry's 
premier biotechnology conference for the Asia Pacific region and has 
proved its relevance to the Australian and international biotechnology 
industries, attracting more than 1,100 participants including 233 
international participants from 20 countries. This program presents an 
opportunity for the entire gamut of U.S. biotech companies looking to 
sell into Australia and spring board into Asia.
    A U.S. Department of Commerce-led trade mission offers an 
attractive entr[eacute]e for U.S. firms in the Australian market.

Mission Goals

    The goals of the trade mission to Australia are to (1) increase 
U.S. exports

[[Page 35354]]

to Australia, (2) introduce U.S. participants to potential strategic 
partners, (3) introduce U.S. participants to industry and government 
officials in Australia to learn about various opportunities, and (4) to 
educate the participants about trade policy and regulatory matters 
involved in doing business in Australia.

Mission Scenario

    In Melbourne, the U.S. mission members will be briefed by 
International Trade Administration CS staff, and other key U.S. 
government officials. Senior American Consulate officials will host a 
networking event for the group with Australian biotech and life science 
industry organizations and multipliers. During the mission, U.S. 
participants will benefit from attending the AusBiotech National 
Conference, customized one-on-one matchmaking with potential partners 
using the biopartnering.com platform, an efficient and easy to use 
personalized intelligent scheduling internet platform that facilitates 
scheduling appointments to connect with key people. And, receive a 
market briefing by the International Trade Administration Commercial 
Specialist for the biotech life science sector at the American 
Consulate, and networking activities. A site visit to Australia's top 
biotech company and/or leading research institution will be offered.
    Participation in the mission will include the following:
     Pre-travel briefings/webinar on the Australian market and 
doing business in Australia;
     Pre-scheduled meetings with potential partners in 
Australia via the biopartnering.com platform;
     Transportation to a site visit to Australia's top biotech 
company and/or leading research institution;
     Meetings with Australian government officials;
     Participation in AusBiotech National Conference;
     Participation in the U.S. Pavilion at the BioIndustry 
Exhibition at AusBiotech;
     Participation in industry networking events in Melbourne;
     Meetings with International Trade Administration CS 
Australia's life science industry specialist.

Proposed Timetable

    Mission participants will be encouraged to arrive October 28 or 29, 
2012 and the mission program will proceed from October 29 through 
November 2, 2012.

----------------------------------------------------------------------------------------------------------------
 
----------------------------------------------------------------------------------------------------------------
October 29.......................................................  Melbourne
                                                                      Arrive Melbourne.
                                                                      Day at leisure.
                                                                      Early evening no-host group dinner
October 30.......................................................  Melbourne.
                                                                      Australia market breakfast briefing.
                                                                      Site visit.
                                                                      Networking luncheon and Australian
                                                                       biotechnology briefing.
                                                                      Evening reception.
October 31.......................................................  Melbourne
                                                                      AusBiotech National Conference 2012.\1\
                                                                      BioPartnering business matchmaking
                                                                       appointments.
                                                                      Conference evening welcome reception.
November 1.......................................................  Melbourne
                                                                      AusBiotech National Conference 2012
                                                                       BioPartnering business matchmaking
                                                                       appointments.
                                                                      Conference evening dinner.
November 2.......................................................  Melbourne
                                                                      AusBiotech National Conference 2012.
                                                                      BioPartnering business matchmaking
                                                                       appointments.
                                                                      Conference Closing Reception.
----------------------------------------------------------------------------------------------------------------
\1\ AusBiotech National Conference fee and conference evening dinner on November 1 are included in the mission
  participation fee.

Participation Requirements

    All parties interested in participating in the Biotech Life 
Sciences Trade Mission to Australia must complete and submit an 
application for consideration by the Department of Commerce. All 
applicants will be evaluated on their ability to meet certain 
conditions and best satisfy the selection criteria as outlined below. A 
minimum of 10 and a maximum of 12 participants will be selected for the 
mission from the applicant pool. U.S. companies already involved with 
and/or doing business in Australia as well as U.S. companies seeking 
exposure to the market for the first time are encouraged to apply.

Fees and Expenses

    After a company or trade association has been selected to 
participate in the mission, a participation fee paid to the U.S. 
Department of Commerce is required. The participation fee for one 
company representative will be $4,504 for small or medium-sized 
enterprises (SME) \2\ and $5,321 for large companies, which will cover 
one representative. The fee for each additional firm representative 
(large firm or SME/trade association) is $1,370.\3\ The Commercial 
Service will assist in booking hotels at favorable rates, but lodging 
costs, meals and incidental expenses will be the responsibility of each 
mission participant.
---------------------------------------------------------------------------

    \2\ An SME is defined as a firm with 500 or fewer employees or 
that otherwise qualifies as a small business under SBA regulations. 
Parent companies, affiliates, and subsidiaries will be considered 
when determining business size. The dual pricing reflects the 
Commercial Service's user fee schedule that became effective May 1, 
2008.
    \3\ The mission participation fee includes the AusBiotech 
National Conference registration fee and conference evening dinner 
on November 1.
---------------------------------------------------------------------------

Conditions for Participation

     An applicant must submit a completed and signed mission 
application and supplemental application materials, including adequate 
information on the company's products and/or services, primary market 
objectives, and goals for participation. If the U.S. Department of 
Commerce receives an incomplete application, the Department may reject 
the application, request additional information, or take the lack of 
information into account when evaluating the applications.
     Each applicant must also certify that the products and 
services it seeks to export through the mission are either produced in 
the United States, or, if not, marketed under the name of a U.S. firm 
and have at least fifty-one percent U.S. content.

[[Page 35355]]

     In the case of a trade association or trade organization, 
the applicant must certify that for each company to be represented by 
the association or trade organizations, the products and/or services 
the represented company seeks to export are either produced in the 
United States or, if not, marketed under the name of a U.S. firm and 
have at least fifty-one percent U.S. content.

Selection Criteria for Participation

    Selection will be based on the following criteria:
     Suitability of a company's (or in the case of a trade 
association or trade organization, represented companies') products or 
services to the mission's goals
     Company's (or in the case of a trade association or trade 
organization, represented companies') potential for business in 
Australia, including likelihood of exports resulting from the trade 
mission
     Consistency of the applicant's (or in the case of a trade 
association or trade organization, represented companies') goals and 
objectives with the stated scope of the trade mission
    Referrals from political organizations and any documents containing 
references to partisan political activities (including political 
contributions) will be removed from an applicant's submission and not 
considered during the selection process.

Timeframe for Recruitment and Applications

    Mission recruitment will be conducted in an open and public manner, 
including publication in the Federal Register, posting on the Commerce 
Department trade mission calendar (http://export.gov/trademissions/) 
and other Internet web sites, press releases to general and trade 
media, direct mail, notices by industry trade associations and other 
multiplier groups, and publicity at industry meetings, symposia, 
conferences, and trade shows.
    Recruitment for the mission will begin immediately and close on 
July 15, 2012. Selection decisions will be made on a rolling basis 
until 10-12 participants are selected. Although applications will be 
accepted through July 15, 2012, interested U.S. firms and trade 
associations are encouraged to submit their applications as soon as 
possible. We will inform applicants of selection decisions as the 
decisions are made. Applications received after July 15, 2012 will be 
considered only if space and scheduling constraints permit.

Contacts

U.S. Commercial Service Domestic Contact

Aileen Nandi, Senior Commercial Officer, San Jose U.S. Export 
Assistance Center, 408-535-2757, ext. 102, Aileen.Nandi@trade.gov.
Gabriela Zelaya, International Trade Specialist, San Jose U.S. Export 
Assistance Center, 408-535-2757, ext. 107, Gabriela.Zelaya@trade.gov.

U.S. Commercial Service Australia Contacts

Joe Kaesshaefer, Senior Commercial Officer, American Consulate 
General--Sydney, Tel: +61-2-9373-9201, Joe.Kaesshaefer@trade.gov.
Monique Roos, Commercial Specialist, American Consulate General--
Sydney, Tel: +61-2-9373-9210, Monique.Roos@trade.gov.

Elnora Moye,
Trade Program Assistant.
[FR Doc. 2012-14452 Filed 6-12-12; 8:45 am]
BILLING CODE 3510-FP-P